BD (Becton, Dickinson and Company)
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Bard_Medical
gptkb:CareFusion_Corporation |
| gptkbp:awards |
Fortune 500
Best Places to Work World's_Most_Admired_Companies |
| gptkbp:CEO |
gptkb:Tom_Polen
|
| gptkbp:employees |
approximately 70,000
|
| gptkbp:focus |
Improving healthcare
Reducing healthcare costs Enhancing patient safety Advancing medical technology |
| gptkbp:founded |
1897
|
| gptkbp:founder |
gptkb:Maxwell_Becton
gptkb:Fairleigh_S._Dickinson |
| gptkbp:global_presence |
Over 50 countries
|
| gptkbp:headCoach |
70,000+
Sales representatives Support staff Global workforce Diverse workforce Research scientists Skilled professionals Manufacturing staff |
| gptkbp:headquarters |
gptkb:Franklin_Lakes,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
BD (Becton, Dickinson and Company)
|
| gptkbp:industry |
Medical technology
|
| gptkbp:market |
Medical devices
Pharmaceuticals Laboratory equipment Diagnostics |
| gptkbp:partnerships |
Government agencies
Research institutions Healthcare_organizations |
| gptkbp:patentCitation |
Over 10,000
|
| gptkbp:products |
Surgical instruments
Needles Syringes Diagnostic_systems |
| gptkbp:researchAndDevelopment |
$1.5 billion annually
|
| gptkbp:revenue |
$17.1 billion (2022)
|
| gptkbp:social_responsibility |
Sustainability initiatives
Community health programs Global health initiatives Employee volunteerism Diversity and inclusion efforts |
| gptkbp:stockExchange |
gptkb:NYSE
BDX |
| gptkbp:subsidiary |
gptkb:CareFusion
Cypress_Diagnostics |
| gptkbp:website |
www.bd.com
|